GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
1.320
+0.010 (0.76%)
At close: Jun 26, 2026, 4:00 PM EDT
1.280
-0.040 (-3.03%)
After-hours: Jun 26, 2026, 7:59 PM EDT
GeoVax Labs Employees
GeoVax Labs had 19 employees as of December 31, 2025. The number of employees increased by 2 or 11.76% compared to the previous year.
Employees
19
Change (1Y)
2
Growth (1Y)
11.76%
Revenue / Employee
$44,857
Profits / Employee
-$1,124,686
Market Cap
4.58M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| CollPlant Biotechnologies | 39 |
| Genprex | 13 |
| TransCode Therapeutics | 12 |
| Ensysce Biosciences | 10 |
| Dermata Therapeutics | 9 |
| Enveric Biosciences | 6 |
| Alzamend Neuro | 6 |
GOVX News
- 4 weeks ago - GeoVax Labs Transcript: Investor update - Transcripts
- 4 weeks ago - GeoVax Labs discontinues development of COVID-19 vaccine candidate - TheFly
- 4 weeks ago - Roth Capital ‘strongly’ agrees with GeoVax ending COVID-19 development - TheFly
- 4 weeks ago - GeoVax Labs files to sell 7.64M shares of common stock for holders - TheFly
- 4 weeks ago - GeoVax Labs Registration statement: Registration filing - Filings
- 5 weeks ago - 3 Penny Stocks to Watch Now, 5/19/26 - TipRanks
- 5 weeks ago - GeoVax Labs Proxy statement: Proxy filing - Filings
- 6 weeks ago - GeoVax Labs Quarterly report: Q1 2026 - Filings